Pacira BioSciences, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Pacira BioSciences, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Pacira BioSciences, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 1, 2024 was 46.2M shares, a 0.57% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 46.2M -264K -0.57% Nov 1, 2024 10-Q 2024-11-06
Q2 2024 46.1M -290K -0.63% Jul 26, 2024 10-Q 2024-07-30
Q1 2024 46.5M +512K +1.11% Feb 26, 2024 10-K 2024-02-29
Q3 2023 46.4M +556K +1.21% Nov 1, 2023 10-Q 2023-11-02
Q2 2023 46.4M +593K +1.29% Aug 1, 2023 10-Q 2023-08-02
Q1 2023 46M +552K +1.22% May 1, 2023 10-Q 2023-05-03
Q3 2022 45.9M +1.34M +3% Nov 1, 2022 10-Q 2022-11-03
Q2 2022 45.8M +1.37M +3.08% Aug 1, 2022 10-Q 2022-08-03
Q1 2022 45.4M +1.41M +3.21% Apr 29, 2022 10-Q 2022-05-04
Q3 2021 44.5M +1.1M +2.53% Oct 31, 2021 10-Q 2021-11-03
Q2 2021 44.5M +1.71M +4.01% Aug 1, 2021 10-Q 2021-08-03
Q1 2021 44M +1.9M +4.52% May 2, 2021 10-Q 2021-05-04
Q3 2020 43.4M +1.71M +4.11% Oct 25, 2020 10-Q 2020-10-30
Q2 2020 42.7M +1.11M +2.66% Aug 2, 2020 10-Q 2020-08-06
Q1 2020 42.1M +824K +2% May 3, 2020 10-Q 2020-05-07
Q3 2019 41.7M +617K +1.5% Nov 3, 2019 10-Q 2019-11-08
Q2 2019 41.6M +675K +1.65% Aug 4, 2019 10-Q 2019-08-08
Q1 2019 41.3M +565K +1.39% Apr 28, 2019 10-Q 2019-05-02
Q3 2018 41.1M +544K +1.34% Oct 28, 2018 10-Q 2018-11-01
Q2 2018 41M +619K +1.53% Jul 26, 2018 10-Q 2018-08-02
Q1 2018 40.7M +638K +1.59% Apr 26, 2018 10-Q 2018-05-03
Q3 2017 40.6M +3.17M +8.47% Nov 5, 2017 10-Q 2017-11-08
Q2 2017 40.3M +3.06M +8.22% Jul 27, 2017 10-Q 2017-08-02
Q1 2017 40.1M +2.93M +7.87% Apr 25, 2017 10-Q 2017-05-04
Q3 2016 37.4M +645K +1.75% Oct 27, 2016 10-Q 2016-11-02
Q2 2016 37.3M +631K +1.72% Jul 31, 2016 10-Q 2016-08-04
Q1 2016 37.2M +724K +1.99% Apr 25, 2016 10-Q 2016-05-02
Q3 2015 36.8M +702K +1.95% Oct 25, 2015 10-Q 2015-10-27
Q2 2015 36.6M +755K +2.1% Jul 26, 2015 10-Q 2015-07-30
Q1 2015 36.4M +788K +2.21% Apr 23, 2015 10-Q 2015-04-30
Q3 2014 36.1M +2.52M +7.5% Oct 28, 2014 10-Q 2014-10-30
Q2 2014 35.9M +2.58M +7.73% Jul 25, 2014 10-Q 2014-07-31
Q1 2014 35.7M +2.61M +7.89% Apr 24, 2014 10-Q 2014-05-01
Q4 2013 33.7M Feb 14, 2014 10-K 2014-02-25
Q3 2013 33.5M +985K +3.03% Oct 24, 2013 10-Q 2013-10-31
Q2 2013 33.3M +896K +2.77% Jul 26, 2013 10-Q 2013-08-06
Q1 2013 33M +7.64M +30.1% Apr 29, 2013 10-Q 2013-05-08
Q3 2012 32.6M +15.3M +88.9% Oct 25, 2012 10-Q 2012-11-01
Q2 2012 32.4M +15.2M +88.1% Aug 1, 2012 10-Q 2012-08-09
Q1 2012 25.4M Mar 23, 2012 10-K 2012-03-27
Q3 2011 17.2M Oct 24, 2011 10-Q 2011-10-31
Q2 2011 17.2M Aug 1, 2011 10-Q 2011-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.